Loading clinical trials...
Loading clinical trials...
Effects of Probiotic VSL#3 on Expression of Small Intestinal Mucosal Renin-angiotensin System and Glucose Absorption in Man - a Doubleblind, Randomized Parallel Arm Placebo Controlled Exploratory Study in Healthy Volunteers
Conditions
Interventions
VSL#3
Placebo
Locations
1
Sweden
Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital
Gothenburg, Sweden
Start Date
December 1, 2011
Primary Completion Date
July 1, 2013
Completion Date
July 1, 2013
Last Updated
October 15, 2021
Lead Sponsor
Göteborg University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions